NCT00326300View on ClinicalTrials.gov

A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

560

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

August 31, 2007

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

methylphenidate hydrochloride extended-release tablets

All Listed Sponsors

lead

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

NCT00326300 - A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder | Biotech Hunter | Biotech Hunter